Penn Medicine Abramson Cancer Center


 

Managing mNSCLC Patients: DFS Data on Adjuvant Osimertinib After Resection, Nivo/Ipi & Nivo/Ipi + Chemo for Patients Without a Molecular Target

0 views
March 22, 2021
Comments 0
Login to view comments. Click here to Login